Pliant Therapeutics (PLRX) Consolidated Net Income (2020 - 2025)
Historic Consolidated Net Income for Pliant Therapeutics (PLRX) over the last 6 years, with Q3 2025 value amounting to -$26.3 million.
- Pliant Therapeutics' Consolidated Net Income rose 5446.74% to -$26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$175.5 million, marking a year-over-year increase of 1298.19%. This contributed to the annual value of -$210.3 million for FY2024, which is 3035.16% down from last year.
- According to the latest figures from Q3 2025, Pliant Therapeutics' Consolidated Net Income is -$26.3 million, which was up 5446.74% from -$43.3 million recorded in Q2 2025.
- In the past 5 years, Pliant Therapeutics' Consolidated Net Income registered a high of -$22.8 million during Q2 2021, and its lowest value of -$57.8 million during Q3 2024.
- Its 5-year average for Consolidated Net Income is -$37.8 million, with a median of -$37.5 million in 2023.
- Per our database at Business Quant, Pliant Therapeutics' Consolidated Net Income tumbled by 30723.55% in 2021 and then surged by 5446.74% in 2025.
- Quarter analysis of 5 years shows Pliant Therapeutics' Consolidated Net Income stood at -$24.5 million in 2021, then tumbled by 42.92% to -$35.1 million in 2022, then decreased by 17.25% to -$41.1 million in 2023, then dropped by 20.98% to -$49.7 million in 2024, then surged by 47.11% to -$26.3 million in 2025.
- Its last three reported values are -$26.3 million in Q3 2025, -$43.3 million for Q2 2025, and -$56.2 million during Q1 2025.